Drug intelligence / Profile preview

Multivit

Development stage: Unknown
Lead developer: Triman
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration: Oral

Overview

Multivit is an oral multivitamin supplement manufactured by Triman, an Indonesian pharmaceutical company. It is formulated to provide essential vitamins necessary for maintaining health and preventing nutritional deficiencies. The product is typically used as a dietary supplement to support the immune system, enhance energy metabolism, and ensure adequate intake of micronutrients during recovery from illness or in individuals with restricted diets. It is part of Triman's supplement portfolio and is marketed for general nutritional supplementation.

Brand names: Multivit
Other names: Multivit Triman

Beyond the preview

Go deeper on Multivit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multivit.

Explore the full profile